Pacific Shuanglin Bio-pharmacy News

Pacific Shuanglin Bio-pharmacy: Pre-disclosure announcement of the shareholding reduction plan by shareholders holding more than 5% and some directors.

00:00

Pacific Shuanglin Bio-pharmacy: Investor relations activity record form for August 7, 2024.

Aug 8 19:24

Pacific Shuanglin Bio-pharmacy: 2024 Interim Performance Forecast

Jul 11 00:00

Pacific Shuanglin Bio-pharmacy: Announcement of Resolutions of the Seventh Meeting (Emergency Meeting) of the Tenth Board of Directors.

Jun 27 00:00

Pacific Shuanglin Bio-pharmacy: Announcement regarding the cancellation of expired and unexercised stock options.

Jun 27 00:00

Pacific Shuanglin Bio-pharmacy: Legal opinion of Jia Yuan Law Firm, Peking, on the cancellation of the 2020 stock options and restrictive stock incentive plan of Paz Pharmaceutics Co., Ltd. that have expired but not yet exercised.

Jun 27 00:00

Pacific Shuanglin Bio-pharmacy: Announcement of the resolution of the Fifth Session of the Tenth Supervisory Board (Emergency Meeting).

Jun 27 00:00

Pacific Shuanglin Bio-pharmacy: Announcement on the Implementation of Profit Distribution for the Year 2023.

Jun 22 00:00

Pacific Shuanglin Bio-pharmacy: Announcement on the release of pledge of shares by company shareholders.

Jun 18 00:00

Pacific Shuanglin Bio-pharmacy: Notice on Wholly-owned Subsidiaries Obtaining Drug Clinical Trial Approval Notice

May 23 00:00

Pacific Shuanglin Bio-pharmacy: May 20, 2024 Investor Relations Activity Schedule

May 22 18:04

Pacific Shuanglin Bio-pharmacy: Legal Opinion of Beijing Jiayuan Law Firm on the 2023 Annual General Meeting of Shareholders of Paisi Shuanglin Biopharmaceutical Co., Ltd.

May 22 00:00

Pacific Shuanglin Bio-pharmacy: Announcement of Resolutions of the 2023 Annual General Meeting of Shareholders

May 22 00:00

Pacific Shuanglin Bio-pharmacy: Announcement on the completion of the share reduction plan for shareholders holding 5% or more of the shares

May 11 00:00

Pacific Shuanglin Bio-pharmacy: Announcement on participating in the 2024 Online Investor Group Reception Day for Listed Companies in the Shanxi Region

May 10 00:00

Pacific Shuanglin Bio-pharmacy: May 7, 2024 Investor Relations Activity Schedule

May 9 16:12

Pacific Shuanglin Bio-pharmacy: Announcement on Jixi Donghai Pasfike Single Plasma Collection Co., Ltd. obtaining a single plasma collection license

May 9 00:00

Pacific Shuanglin Bio-pharmacy: Pailin Biotech: Investor Relations Activity Record Form for April 28, 2024

Apr 29 18:12

Pacific Shuanglin Bio-pharmacy: 2023 Annual Audit Report

Apr 27 00:00

Pacific Shuanglin Bio-pharmacy: Pailin Biotech's 2023 Independent Director Debriefing Report (Zhang Jingang)

Apr 27 00:00